Published in J Lipid Res on September 01, 1996
Immunologic studies of juvenile rheumatoid arthritis. Arthritis Rheum (1972) 1.65
Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis. Arthritis Rheum (1972) 1.51
Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol (1997) 1.38
Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors). Clin Exp Immunol (1974) 1.26
Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection. AIDS Res Hum Retroviruses (1988) 1.08
Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis. Ann Rheum Dis (1974) 1.08
Juvenile rheumatoid arthritis. Cellular hypersensitivity and selective IgA deficiency. Clin Exp Immunol (1972) 1.04
Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int (1999) 1.03
Further description of early clinically silent lupus nephritis. Lupus (2006) 0.96
Failure of cell-mediated effector mechanisms in lung cancer. J Natl Cancer Inst (1984) 0.93
Novel DNA-protein complex and a large DNA in SLE cryoprecipitates. Clin Exp Immunol (1986) 0.90
Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesis. J Clin Immunol (1987) 0.90
Decreased T-cell proliferative response to common environmental antigens could be an indicator of early human immunodeficiency virus-mediated lymphocyte lesions. Clin Diagn Lab Immunol (1995) 0.89
Silent nephritis in systemic lupus erythematosus. Lupus (2003) 0.89
Immune response in malnutrition. Effect of protein deficiency on the DNA synthetic response to alloantigens. Int Arch Allergy Appl Immunol (1978) 0.88
Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int (1992) 0.87
Cellular immunity in current active pulmonary tuberculosis. Am Rev Respir Dis (1991) 0.86
Physiological aspects of circulating immune complexes in the normal population. Clin Exp Immunol (1982) 0.86
Studies of human natural killer cytotoxic factor (NKCF): characterization and analysis of its mode of action. Adv Exp Med Biol (1985) 0.85
Opsonization by anti-dsDNA antibodies of apoptotic cells in systemic lupus erythematosus. Autoimmunity (2007) 0.85
Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice. J Natl Cancer Inst (1979) 0.85
Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins. Immunology (1997) 0.84
Synthesis of C(10)-halogenated prostaglandins. J Pharm Sci (1994) 0.83
Lipoprotein lipase expression in natural killer cells and its role in their cytotoxic activity. Immunology (1994) 0.83
Expression of different lipoprotein receptors in natural killer cells and their effect on natural killer proliferative and cytotoxic activity. Immunology (1995) 0.82
Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2. Clin Exp Immunol (1992) 0.81
Antigammaglobulins in normal individuals and in patients with adult and juvenile rheumatoid arthritis and osteoarthritis. Rheumatology (1975) 0.81
Changes in the development of the 3LL tumor in syngeneic mice in relation to protein calorie malnutrition. Clin Immunol Immunopathol (1978) 0.80
Low density lipoprotein receptor expression and function in human polymorphonuclear leucocytes. Clin Exp Immunol (1997) 0.80
Assessment of former and newly developed HBV assays in a Third World setting. J Med Virol (1992) 0.80
Immunopathogenic aspects of infection by the human immunodeficiency virus in Venezuela. Bull Pan Am Health Organ (1989) 0.80
Expression and function of low-density lipoprotein receptors in CD3-CD16+CD56+ cells: effect of interleukin 2. Cell Immunol (1996) 0.80
Characterization of local memory cells in stage-classified pulmonary tuberculosis: preliminary observations. Scand J Immunol (1998) 0.79
Increased peroxide production by polymorphonuclear cells of chronic hepatitis C virus-infected patients. Clin Immunol Immunopathol (1998) 0.79
Solid phase C1q microassay for the rapid detection of circulating immune complexes. J Immunol Methods (1983) 0.78
Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes. Clin Exp Immunol (1998) 0.77
The proliferation and function of human mononuclear leukocytes and natural killer cells in serum-free medium. J Immunol Methods (1985) 0.77
Effects of different lipoproteins on the proliferative response of interleukin-2-activated T lymphocytes and large granular lymphocytes. Clin Sci (Lond) (1995) 0.77
CD3- and CD28-activating pathways in HCV infection. Viral Immunol (1994) 0.77
Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signals. Clin Immunol Immunopathol (1993) 0.77
Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells. Nat Immun Cell Growth Regul (1985) 0.77
Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virus. Prog Clin Biol Res (1991) 0.77
Serum leptin levels in different types of hypertension during pregnancy. Res Commun Mol Pathol Pharmacol (2000) 0.77
Cell-mediated effector mechanisms in aging humans. Int Arch Allergy Appl Immunol (1982) 0.76
A double-blind, cross-over study using salbutamol, beclomethasone, and a combination of both in bronchial asthma. J Asthma (1995) 0.76
Nitric oxide in different types of hypertension during pregnancy. Clin Sci (Lond) (1997) 0.76
Activity profile in multiple sclerosis: an integrative approach. A preliminary report. Mult Scler (2002) 0.76
Antihypertensive treatment decreased serum leptin levels in severe preeclampsia during pregnancy. Ann Nutr Metab (2001) 0.75
[Absence of delta agent infection in high risk male subjects infected with B virus and human immunodeficiency virus]. G E N (1992) 0.75
[Molecular biology techniques for detection of delta hepatitis virus. I: Obtaining the specific diagnostic probe]. G E N (1992) 0.75
Immunopathology of human schistosomiasis mansoni. I. Immunomodulatory influences on T cell function. Rev Inst Med Trop Sao Paulo (1989) 0.75
Cytotoxic activity of normal and Herpesvirus saimiri-transformed nonhuman primate cells. Cell Immunol (1985) 0.75
Clinical immunology as a new specialty in public health: a model for developing countries. Bull Pan Am Health Organ (1982) 0.75
Proliferative response in solid culture of T cells from patients with extrinsic bronchial asthma. Immunol Invest (1986) 0.75
Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela. Tissue Antigens (2010) 0.75
Further aspects of T cell function in systemic lupus erythematosus. Immunol Commun (1982) 0.75
Immunology of human gastric cancer: a preliminary report. Cancer (1982) 0.75
Proliferative response in solid culture of T cells from healthy aged subjects. Gerontology (1985) 0.75
Immunopathology of human schistosomiasis mansoni. II. NK activity and stimulation by specific antigen. Rev Inst Med Trop Sao Paulo (1989) 0.75
Characterization of cell-mediated immunity in long-term survivors of gastric or colorectal cancer. Am J Surg (1984) 0.75
Total serum IgE levels in Venezuelan schoolchildren. Clin Allergy (1983) 0.75
Seronegative spondyloarthropathies and HLA antigens in a Mestizo population. Tissue Antigens (1984) 0.75
T cell hyperreactivity to IL-6 in chronic nonviremic HBV carriers despite normal IL-6 receptor or gp130 expression. Viral Immunol (1996) 0.75
Synthesis of modified prostaglandins and their inhibitory activity on natural killer cells. Farmaco (1992) 0.75
HCV RNA sequences in eosinophils of chronic HCV-infected patients. J Med (1999) 0.75
[Immunopathogenic aspects of infection by the human immunodeficiency virus in Venezuela]. Bol Oficina Sanit Panam (1989) 0.75
Synthesis of bicyclic ketones in prostaglandins and their antimitotic activity. Pharmazie (1995) 0.75
Reappraisal of human retroviral infection in Venezuela. AIDS Res Hum Retroviruses (1992) 0.75